Literature DB >> 33768013

Towards a Sustainable Vector-Control Strategy in the Post Kala-Azar Elimination Era.

Rajesh Garlapati1, Eva Iniguez2, Tiago D Serafim2, Prabhas K Mishra1, Basab Rooj1, Bikas Sinha1, Jesus G Valenzuela2, Sridhar Srikantiah1, Caryn Bern3, Shaden Kamhawi2.   

Abstract

Visceral leishmaniasis (VL) is a potentially deadly parasitic disease. In the Indian sub-continent, VL is caused by Leishmania donovani and transmitted via the bite of an infected Phlebotomus argentipes female sand fly, the only competent vector species in the region. The highest disease burden is in the northern part of the Indian sub-continent, especially in the state of Bihar. India, Bangladesh, and Nepal embarked on an initiative, coordinated by World Health Organization, to eliminate VL as a public health problem by the year 2020. The main goal is to reduce VL incidence below one case per 10,000 people through early case-detection, prompt diagnosis and treatment, and reduction of transmission using vector control measures. Indoor residual spraying, a major pillar of the elimination program, is the only vector control strategy used by the government of India. Though India is close to its VL elimination target, important aspects of vector bionomics and sand fly transmission dynamics are yet to be determined. To achieve sustained elimination and to prevent a resurgence of VL, knowledge gaps in vector biology and behavior, and the constraints they may pose to current vector control methods, need to be addressed. Herein, we discuss the successes and failures of previous and current vector-control strategies implemented to combat kala-azar in Bihar, India, and identify gaps in our understanding of vector transmission towards development of innovative tools to ensure sustained vector control in the post-elimination period.
Copyright © 2021 Garlapati, Iniguez, Serafim, Mishra, Rooj, Sinha, Valenzuela, Srikantiah, Bern and Kamhawi.

Entities:  

Keywords:  Bihar; India; Kala-azar; Phlebotomus argentipes; elimination ; vector control; visceral leishmaniasis

Mesh:

Substances:

Year:  2021        PMID: 33768013      PMCID: PMC7985538          DOI: 10.3389/fcimb.2021.641632

Source DB:  PubMed          Journal:  Front Cell Infect Microbiol        ISSN: 2235-2988            Impact factor:   5.293


  89 in total

1.  Risk factors for visceral leishmaniasis in India: further evidence on the role of domestic animals.

Authors:  S P Singh; E Hasker; A Picado; K Gidwani; P Malaviya; R P Singh; M Boelaert; S Sundar
Journal:  Trop Med Int Health       Date:  2010-05-06       Impact factor: 2.622

2.  Identification of bloodmeals in wild caught blood fed Phlebotomus argentipes (Diptera: Psychodidae) using cytochrome b PCR and reverse line blotting in Bihar, India.

Authors:  Rajesh B Garlapati; Ibrahim Abbasi; Alon Warburg; David Poché; Richard Poché
Journal:  J Med Entomol       Date:  2012-05       Impact factor: 2.278

3.  Field trial of an ecological approach for the control of Phlebotomus argentipes using mud & lime plaster.

Authors:  V Kumar; S K Kesari; N K Sinha; A Palit; A Ranjan; K Kishore; R Saran; S K Kar
Journal:  Indian J Med Res       Date:  1995-04       Impact factor: 2.375

4.  Identification of aerobic gut bacteria from the kala azar vector, Phlebotomus argentipes: a platform for potential paratransgenic manipulation of sand flies.

Authors:  Heidi Hillesland; Amber Read; Bobban Subhadra; Ivy Hurwitz; Robin McKelvey; Kashinath Ghosh; Pradeep Das; Ravi Durvasula
Journal:  Am J Trop Med Hyg       Date:  2008-12       Impact factor: 2.345

5.  Discovery of markers of exposure specific to bites of Lutzomyia longipalpis, the vector of Leishmania infantum chagasi in Latin America.

Authors:  Clarissa Teixeira; Regis Gomes; Nicolas Collin; David Reynoso; Ryan Jochim; Fabiano Oliveira; Amy Seitz; Dia-Eldin Elnaiem; Arlene Caldas; Ana Paula de Souza; Cláudia I Brodskyn; Camila Indiani de Oliveira; Ivete Mendonca; Carlos H N Costa; Petr Volf; Aldina Barral; Shaden Kamhawi; Jesus G Valenzuela
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23

6.  Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas.

Authors:  Ana Paula Souza; Bruno Bezerril Andrade; Dorlene Aquino; Petter Entringer; José Carlos Miranda; Ruan Alcantara; Daniel Ruiz; Manuel Soto; Clarissa R Teixeira; Jesus G Valenzuela; Camila Indiani de Oliveira; Cláudia Ida Brodskyn; Manoel Barral-Netto; Aldina Barral
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23

7.  Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial.

Authors:  Albert Picado; Murari L Das; Vijay Kumar; Shreekant Kesari; Diwakar S Dinesh; Lalita Roy; Suman Rijal; Pradeep Das; Mark Rowland; Shyam Sundar; Marc Coosemans; Marleen Boelaert; Clive R Davies
Journal:  PLoS Negl Trop Dis       Date:  2010-01-26

8.  A new strategy for elimination of kala-azar from rural Bihar.

Authors:  C P Thakur
Journal:  Indian J Med Res       Date:  2007-11       Impact factor: 2.375

9.  Immunity to vector saliva is compromised by short sand fly seasons in endemic regions with temperate climates.

Authors:  Fabiano Oliveira; Ekaterina Giorgobiani; Anderson B Guimarães-Costa; Maha Abdeladhim; James Oristian; Lamzira Tskhvaradze; Nikoloz Tsertsvadze; Mariam Zakalashvili; Jesus G Valenzuela; Shaden Kamhawi
Journal:  Sci Rep       Date:  2020-05-14       Impact factor: 4.379

10.  Chemical and environmental vector control as a contribution to the elimination of visceral leishmaniasis on the Indian subcontinent: cluster randomized controlled trials in Bangladesh, India and Nepal.

Authors:  Anand B Joshi; Murari L Das; Shireen Akhter; Rajib Chowdhury; Dinesh Mondal; Vijay Kumar; Pradeep Das; Axel Kroeger; Marleen Boelaert; Max Petzold
Journal:  BMC Med       Date:  2009-10-05       Impact factor: 8.775

View more
  1 in total

1.  Can floral nectars reduce transmission of Leishmania?

Authors:  Evan C Palmer-Young; Ryan S Schwarz; Yanping Chen; Jay D Evans
Journal:  PLoS Negl Trop Dis       Date:  2022-05-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.